To explore the feasibility and effectiveness of optimizing diagnosis and treatment process of BPPV under medical integration mode.

From January 2018 to December 2019, 55 patients with BPPV diagnosed in the Department of Neurology of Jianhu Hospital Affiliated to Nantong University were selected as the pre-process optimization group. From January 2020 to December 2020, 55 patients with BPPV diagnosed and treated after many trainings organized by the medical association unit (after process optimization) were selected as the post-process optimization group. The baseline data, total score of DHI, DHI-emotion, DHI-body, DHI-function, HADS-anxiety and depression were compared between the two groups.

There was no significant difference in gender, age, hypertension, diabetes, low density lipoprotein cholesterol, sleep disturbance between the 2 groups (P>0.05), and the median duration [8 (7, 13), 7(5, 9) d], reduction times [3(2, 4), 2(2, 3) times] and cost comparison [(3157.53±1077.49), (338.51±60.50) yuan] were statistically significant (P<0.05). There was no significant difference in the total scores of DHI, DHI-emotion, DHI-body, DHI-function, HADS-anxiety and depression between the two groups before reduction (P>0.05), but the scores of the two groups after reduction were significantly smaller than those before reduction (P<0.05). After reduction, the HADS-anxiety scores of the two groups were lower in the optimized group than in the pre-optimized group, and the difference was statistically significant (P<0.05), but there was no significant difference in other indexes (P>0.05).

Optimization of diagnosis and treatment scheme for BPPV under medical integration mode is beneficial to the BPPV patients.